Results of the Combined General Meeting of Innate Pharma

Marseille, May 23, 2024, Innate Pharma SA announced the results of the shareholder vote during the Combined General Meeting. All resolutions were adopted. 84 votes were cast out of a total of 36,317,268 shares, representing a quorum of 44.92% of the voting rights.

The two members of the Supervisory Board, whose renewal was proposed, were re-elected. Details of the resolutions, the result of the voting per resolution, and other documents relating to the General Meeting are available on the Company's website.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève